View Attendee List
See you in 2024!

Missed Discovery On Target This Year?

Access the Digital Platform

Missed this year's event? Access content across all of this year's programs On-Demand. At your convenience, access archived presentations for On-Demand learning from anywhere, at any time.

2023 Image Gallery
2022 Video Highlights

This past September 25-28, 2023, over 1,100 international attendees (90% in-person) learned and networked together at our 20th Anniversary Discovery on Target.

The sold-out Exhibit Hall featured 93 companies with novel solutions and technologies. These leading providers extended their impact across agenda presentations highlighting new offerings to the scientific community. Attendees also enjoyed 100+ posters by students, academia, and industry revealing drug discovery research on the cutting edge.

The event included 275+ expert speakers, 16 conference tracks, 2 symposia, 8 interactive courses, and 1 in-depth training seminar. Interest and track hopping were healthy across topics, from popular kinases and immunomodulation to protein degradation and AI; new or expanded programming on transcription factors and small molecules for cancer targets; stalwarts like antibodies; and plenty more.

For a review of fragment-based drug discovery talks written by
Dr. Daniel A. Erlanson of Frontier Medicines, click here for his Practical Fragments blogpost:

Thank you for contributing to the life science and lifeblood of Discovery on Target, via your diverse perspectives and targets. Feel free to share ideas and topics with me and submit a speaker proposal for 2024. Our team looks forward to welcoming you back to Boston for our 22nd Annual event this
September 30 - October 3, 2024
. See you next fall!

An-Dinh Nguyen
Team Lead, Discovery on Target

Read attendee, sponsor and speaker testimonials here!

Join Us in Boston for Discovery On Target 2023!

Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.

We aim to meet your research needs. Visit numerous concurrent sessions for informative presentations, lively dialogue, and meaningful connections with peers. Customize your experience further through focused short courses and a training seminar, interactive group discussions, and networking options that help you engage with experts and solutions providers.

Our 20th Anniversary event brings back popular topics like immunomodulation, protein degraders, and RNA, plus new, expanded, or returning programming on transcription factors, small molecules for cancer targets, and kinases.






Research Posters


Conference Tracks




Training Seminar


In-Person Short Courses




Countries Represented

As of 9/18/23

2023 Premier Sponsors

CausalyCharles-River  GenScript-ProBio

View All Sponsors

2023 Plenary Keynote Program

Jay E. Bradner, MD, PhD Photo

The New Science of Therapeutics
Jay E. Bradner, MD, Physician Scientist, Former President, Novartis Institutes for BioMedical Research, Inc.

Anne E. Carpenter, PhD

Accelerating Drug Discovery Using Machine Learning and Cell Painting Images
Anne E. Carpenter, PhD, Senior Director, Imaging Platform & Institute Scientist, Broad Institute

Shantanu Singh, PhD

Shantanu Singh, PhD, Senior Group Leader, Machine Learning, Imaging Platform, Broad Institute

Register with Confidence

In Person Attendance Video
Virtual Acesss Video

Flexible Registration – Seamlessly switch between In-Person and/or Virtual

Select an in-person or virtual option, and you have the flexibility to switch your preferred event experience at any time leading up to the conference. Our flexible registration is designed to take the uncertainties out of these uncertain times.

Registration Options